Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Invasive ductal and lobular carcinoma and receptor status in the genetic context of breast cancer.

Scientific reports - 15 Apr 2026

Al-Masri Mahmoud, Alayyan Osama, Safi Yasmin

Abstract excerpt

Invasive lobular carcinoma (ILC) represents about 10% of invasive breast cancers and is increasingly considered a unique disease entity. Certain genetic mutations predispose patients to ILC, as such this study aims to explore the ILC and IDC (invasive ductal carcinoma) in a genetic context. This is a retrospective chart review study. Any patient diagnosed with either ILC or IDC and a germline mutation with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms
Share to Carcinoma, Ductal, Breast

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Lobular

Share to Erb-b2 Receptor Tyrosine Kinases

Share to Germ-Line Mutation

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Open in PubMed Open full text

Identifiers

PMID: 41986415
DOI: 10.1038/s41598-026-44029-y
PMCID: PMC13243571

Genes

ATM
BRCA2
CDH1
CHEK2
EPCAM
PALB2
PMS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Invasive ductal and lobular carcinoma and receptor status in the genetic context of breast cancer.PMID 41986415Read ↗

Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li‐Fraumeni syndrome) germline mutationsSemantic proximity Read ↗

Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status.Semantic proximity Read ↗

Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast.Semantic proximity Read ↗

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.Semantic proximity Read ↗

Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers.Semantic proximity Read ↗

Clinicopathological and genetic analysis of 55 male patients with invasive breast cancerSemantic proximity Read ↗

Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breastSemantic proximity Read ↗

Multi-omic characterization of ILC and ILC-like cell lines as part of ILC cell line encyclopedia (ICLE) defines new models to study potential biomarkers and explore therapeutic opportunitiesSemantic proximity Read ↗

Comparative Analysis of Clinical and Molecular Characteristics in Invasive Ductal Carcinoma of the BreastSemantic proximity Read ↗

Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations.Semantic proximity Read ↗

Genomic Characterization of Primary Invasive Lobular Breast Cancer.Semantic proximity Read ↗

The Genomic Landscape of Lobular Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.